Gcgtm1.1(cre/ERT2)Gkg
Targeted Allele Detail
|
Symbol: |
Gcgtm1.1(cre/ERT2)Gkg |
Name: |
glucagon; targeted mutation 1.1, George K Gittes |
MGI ID: |
MGI:5898440 |
Synonyms: |
GcgCreER2, Gcgtm1(cre/ERT2)Cshi |
Gene: |
Gcg Location: Chr2:62304874-62313994 bp, - strand Genetic Position: Chr2, 35.85 cM
|
Alliance: |
Gcgtm1.1(cre/ERT2)Gkg page
|
|
|
Allele Type: |
|
Targeted (Inducible, Null/knockout, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Gcgtm1.1(cre/ERT2)Gkg expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Gcg (MGI:95674) |
|
|
|
|
Mutation details: The targeting construct is designed to insert a creERT2 fusion gene (a Cre recombinase fused to a human estrogen receptor ligand binding domain) followed by an SV40 polyadenylation signal, and a FRT-flanked neomycin resistance (neo) cassette into exon 2 of the gene. Flp-mediated recombination removed the FRT-flanked neo cassette.
(J:256199)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Gcg
(mouse)
|
|
|
|
|
Original: |
J:256199 Shiota C, et al., Gcg (CreERT2) knockin mice as a tool for genetic manipulation in pancreatic alpha cells. Diabetologia. 2017 Dec;60(12):2399-2408 |
All: |
5 reference(s) |
|